Johnson & Johnson
Johnson & Johnson is a United States-based company in the Healthcare sector with a market capitalisation of $615.9B. Its FinScore is 61/100; its highest-scoring layer is Quality (89) and its lowest is Value (28). The shares trade at 38.3x trailing earnings and are up 23% year to date.
Share price performance
About Johnson & Johnson
www.jnj.comJohnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- HQ
- United States
- Fiscal year-end
- December
- Trading currency
- USD
- Reporting currency
- USD
- Fundamentals updated
- 5 days ago
- Market cap
- $615.9B
- Shares outstanding
- 2.4B
- P/E (TTM)
- 38.3x
- Dividend yield (TTM)
- 2.07%
- Beta (issuer)
- 0.23
- Revenue (latest FY)
- $94.2B
Revenue breakdown
- Innovative Medicine64.1%$60.4B
- MedTech35.9%$33.8B
FinScore
As of 2026-10-19Snapshot
Ownership
As of 2026-06-30Sign up or log in to see Analysis
Analysis for Johnson & Johnson is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Johnson & Johnson is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Johnson & Johnson is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Johnson & Johnson is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Johnson & Johnson is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Johnson & Johnson is available to Finryse members. The Overview stays open to everyone; creating an account is free.